Testing - Email .html file
SAN FRANCISCO--(BUSINESS WIRE)--Test reacted to the challenging market environment with productivity and restructuring initiatives across its business units, positioning the company for margin recovery and a return to profitable growth. The initial effects of these initiatives have already materialized, and together with raw material cost savings, contributed to EBITDA improvement in Q4 despite sales price pressures.
Full Year 2024
|
FY 2024 |
FY 2023 |
Change |
Change (CER) |
|
$bn |
$bn |
% |
% |
Sales |
28.8 |
32.2 |
-10 |
-7 |
EBITDA |
3.9 |
4.6 |
-15 |
-1 |
Q4 2024
|
Q4 2024 |
Q4 2023 |
Change |
Change (CER) |
|
$bn |
$bn |
% |
% |
Sales |
7.5 |
7.9 |
-5 |
-1 |
EBITDA |
1.1 |
1.0 |
11 |
38 |
Q4 2024
|
Q4 2024 |
Q4 2023 |
Change |
Change (CER) |
|
$bn |
$bn |
% |
% |
Sales |
7.5 |
7.9 |
-5 |
-1 |
EBITDA |
1.1 |
1.0 |
11 |
38 |
